Anges Inc Stock Performance

AMGXF Stock  USD 0.36  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AnGes are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days AnGes Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, AnGes is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow11.5 B
Total Cashflows From Investing Activities-154 M
Free Cash Flow-11.5 B
  

AnGes Relative Risk vs. Return Landscape

If you would invest  36.00  in AnGes Inc on November 18, 2025 and sell it today you would earn a total of  0.00  from holding AnGes Inc or generate 0.0% return on investment over 90 days. AnGes Inc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than AnGes, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

AnGes Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AnGes for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AnGes Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
AnGes Inc generated a negative expected return over the last 90 days
AnGes Inc has some characteristics of a very speculative penny stock
AnGes Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 64.15 M. Net Loss for the year was (13.68 B) with loss before overhead, payroll, taxes, and interest of (26 M).
AnGes Inc has accumulated about 13.21 B in cash with (11.38 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 86.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

AnGes Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AnGes OTC Stock often depends not only on the future outlook of the current and potential AnGes' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AnGes' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding153.1 M
Shares Float162.1 M

AnGes Fundamentals Growth

AnGes OTC Stock prices reflect investors' perceptions of the future prospects and financial health of AnGes, and AnGes fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AnGes OTC Stock performance.

About AnGes Performance

By analyzing AnGes' fundamental ratios, stakeholders can gain valuable insights into AnGes' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AnGes has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AnGes has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.

Things to note about AnGes Inc performance evaluation

Checking the ongoing alerts about AnGes for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for AnGes Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AnGes Inc generated a negative expected return over the last 90 days
AnGes Inc has some characteristics of a very speculative penny stock
AnGes Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 64.15 M. Net Loss for the year was (13.68 B) with loss before overhead, payroll, taxes, and interest of (26 M).
AnGes Inc has accumulated about 13.21 B in cash with (11.38 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 86.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating AnGes' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate AnGes' otc stock performance include:
  • Analyzing AnGes' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AnGes' stock is overvalued or undervalued compared to its peers.
  • Examining AnGes' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating AnGes' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AnGes' management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of AnGes' otc stock. These opinions can provide insight into AnGes' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating AnGes' otc stock performance is not an exact science, and many factors can impact AnGes' otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for AnGes OTC Stock analysis

When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments